CTOs on the Move


 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

MedFlight of Ohio

MedFlight of Ohio is a Columbus, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Healthcare Anchor Network

Healthcare Anchor Network is a collaboration of over 65 healthcare systems in the United States that are committed to leveraging their institutional assets to improve health and well-being by addressing economic and racial inequities in the communities...

Medical Supplies Inc

Medical Supplies Inc is a Waterville, ME-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Can-Med Healthcare

Can-Med Healthcare is a Bedford, NS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

gloStream

gloStream Inc. is a Troy, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.